The Visual Object Tracking challenge VOT2018 is the sixth annual tracker benchmarking activity organized by the VOT initiative. Results of over eighty trackers are presented; many are state-of-the-art trackers published at major computer vision conferences or in journals in the recent years. The evaluation included the standard VOT and other popular methodologies for short-term tracking analysis and a "real-time" experiment simulating a situation where a tracker processes images as if provided by a continuously running sensor. A long-term tracking subchallenge has been introduced to the set of standard VOT sub-challenges. The new subchallenge focuses on long-term tracking properties, namely coping with target disappearance and reappearance. A new dataset has been compiled and a performance evaluation methodology that focuses on long-term tracking capabilities has been adopted. The VOT toolkit has been updated to support both standard short-term and the new longterm tracking subchallenges. Performance of the tested trackers typically by far exceeds standard baselines. The source code for most of the trackers is publicly available from the VOT page. The dataset, the evaluation kit and the results are publicly available at the challenge website 60 .

No abstract

No abstract

The number of tornadoes reported in the United States is believed to be less than the actual incidence of tornadoes, especially prior to the 1990s, because tornadoes may be undetectable by human witnesses in sparsely populated areas. We use a hierarchical Bayesian model to simultaneously correct for population-based sampling bias and estimate tornado density using historical tornado report data.The expected result is that F2-F5 compared to F0-F1 tornado reports would vary less with population density. The results agree with this hypothesis for the 1 following population centers: Atlanta, GA; Champaign, IL; Des Moines, IA. However, the results indicated just the opposite in Oklahoma. We speculate the result is explained by misclassification of tornadoes that were worthy of F2-F5 Fujita scale rating but were classified as F0-F1 tornadoes, thereby artificially decreasing the number of F2-F5 and increasing the number of F0-F1 reports in rural Oklahoma.

Abstractp53, encoded by the tumor suppressor gene TP53, is one of the most important tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53–MDM2 negative feedback loop. Abnormal p53 can be observed in almost all tumors, mainly including p53 mutation and functional inactivation. Blocking MDM2 to restore p53 function is a hotspot in the development of anticancer candidates. Till now, nine MDM2 inhibitors with different structural types have entered clinical trials. However, no MDM2 inhibitor has been approved for clinical application. This review focused on the discovery, structural modification, preclinical and clinical research of the above compounds from the perspective of medicinal chemistry. Based on this, the possible defects in MDM2 inhibitors in clinical development were analyzed to suggest that the multitarget strategy or targeted degradation strategy based on MDM2 has the potential to reduce the dose-dependent hematological toxicity of MDM2 inhibitors and improve their anti-tumor activity, providing certain guidance for the development of agents targeting the p53–MDM2 interaction.